| Hepatotoxicity after immune checkpoint inhibitor therapy in melanoma: natural progression and management BM Huffman, LA Kottschade, PS Kamath, SN Markovic American Journal of Clinical Oncology 41 (8), 760-765, 2018 | 103 | 2018 |
| Coaching versus competency to facilitate professional identity formation AP Sawatsky, BM Huffman, FW Hafferty Academic Medicine 95 (10), 1511-1514, 2020 | 68 | 2020 |
| Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma S Chakrabarti, SH Tella, A Kommalapati, BM Huffman, S Yadav, IB Riaz, ... Journal of gastrointestinal oncology 10 (3), 554, 2019 | 47 | 2019 |
| Resident impression management within feedback conversations: a qualitative study BM Huffman, FW Hafferty, A Bhagra, EL Leasure, WL Santivasi, ... Medical Education 55 (2), 266-274, 2021 | 42 | 2021 |
| Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers BM Huffman, VN Aushev, GL Budde, J Chao, F Dayyani, D Hanna, ... JCO Precision Oncology 6, e2200420, 2022 | 29 | 2022 |
| Survival and prognostic factors in patients with solid pseudopapillary neoplasms of the pancreas BM Huffman, G Westin, S Alsidawi, SR Alberts, DM Nagorney, ... Pancreas 47 (8), 1003-1007, 2018 | 27 | 2018 |
| Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma JM Cleary, B Rouaisnel, A Daina, S Raghavan, LA Roller, BM Huffman, ... NPJ Precision Oncology 6 (1), 61, 2022 | 25 | 2022 |
| Local excision for patients with stage I anal canal squamous cell carcinoma can be curative S Chakrabarti, Z Jin, BM Huffman, S Yadav, RP Graham, DM Lam-Himlin, ... Journal of gastrointestinal oncology 10 (2), 171, 2019 | 23 | 2019 |
| Novel prognostic factors in resected small bowel adenocarcinoma BM Huffman, Z Jin, S Yadav, S Patel, DM Nagorney, MJ Truty, ... Clinical colorectal cancer 18 (3), 218-225, 2019 | 16 | 2019 |
| Early TP53 Alterations Shape Gastric and Esophageal Cancer Development P Sahgal, BM Huffman, DT Patil, WK Chatila, R Yaeger, JM Cleary, ... Cancers 13 (23), 5915, 2021 | 11 | 2021 |
| Emerging role of targeted therapy in metastatic pancreatic adenocarcinoma BM Huffman, H Ellis, AC Jordan, WA Freed-Pastor, K Perez, DA Rubinson, ... Cancers 14 (24), 6223, 2022 | 10 | 2022 |
| Opportunities for utilization of DNA repair inhibitors in homologous recombination repair-deficient and proficient pancreatic adenocarcinoma JM Cleary, BM Wolpin, SK Dougan, S Raghavan, H Singh, B Huffman, ... Clinical Cancer Research 27 (24), 6622-6637, 2021 | 8 | 2021 |
| Solid Pseudopapillary neoplasms of the pancreas: a large American cohort CT Sanhueza, BM Huffman, Z Jin, ML Hartgers, TC Smyrk, G Westin, ... Pancreas 48 (4), e21-e22, 2019 | 7 | 2019 |
| Effect of a MUC5AC antibody (NPC-1C) administered with second-line gemcitabine and nab-paclitaxel on the survival of patients with advanced pancreatic ductal adenocarcinoma: A … BM Huffman, AB Mallick, NK Horick, A Wang-Gillam, PJ Hosein, ... JAMA network open 6 (1), e2249720-e2249720, 2023 | 5 | 2023 |
| Risk stratification using cytomorphologic features in endoscopic ultrasonographic‐guided fine‐needle aspiration diagnosis of pancreatic ductal adenocarcinoma BM Huffman, M Esebua, LJ Layfield, BL Witt, RL Schmidt Diagnostic Cytopathology 43 (8), 613-621, 2015 | 4 | 2015 |
| Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI Cancer H Singh, SJ Klempner, N Melnitchouk, DP Chander, OG Negrea, AK Patel, ... JCO Precision Oncology 7, e2200572, 2023 | 2 | 2023 |
| RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer H Singh, P Sahgal, K Kapner, SM Corsello, H Gupta, R Gujrathi, YY Li, ... Clinical Cancer Research 30 (8), 1669-1684, 2024 | | 2024 |
| Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders BM Huffman, H Singh, LR Ali, N Horick, SJ Wang, MT Hoffman, ... Journal for Immunotherapy of Cancer 12 (1), 2024 | | 2024 |
| A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma BM Huffman, H Feng, K Parmar, J Wang, KS Kapner, B Kochupurakkal, ... Clinical Cancer Research 29 (24), 5047-5056, 2023 | | 2023 |
| Supportive learning environments, impression management and ‘strategic imposterism’: A word of caution BM Huffman, AP Sawatsky Medical Education 57 (12), 1170-1172, 2023 | | 2023 |
